Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06764745Not ApplicableCompleted

Effect of Different Ventilation Modes on POCD in Elderly Patients with Abdominal Wall Hernia

Role: lead

NCT04199325Not ApplicableUnknown

Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial

Role: collaborator

NCT05094167Not ApplicableUnknown

Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients

Role: collaborator

NCT05032014Not ApplicableUnknown

Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer

Role: collaborator

NCT02541539Not ApplicableCompleted

Effects of Lactobacillus Casei on Respiratory and Gastrointestinal Diseases in Adults

Role: collaborator

All 5 trials loaded